// App-Quantinova.ai

MON-1064 : Association of Serum High-Sensitivity C - Reactive Protein to Metabolic Control and Chronic Vascular Complications in Patients with Type 2 Diabetes

Researchers

Presenter

  • Somlak Chuengsamarn

Principal Investigators

  • Suthee Rattanamongkolgul

  • Siwanon Jirawatnotai

Medical Centers

  • HRH Princess Maha Chakri, Bangkok, Thailand

  • Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Nakornnayok, Thailand, Nakornnayok,, Thailand

  • Siriraj Medical School, Mahidol University, Bangkok, Thailand

Locations

  • Thailand

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Peripheral neuropathy

  • Diabetic nephropathy

  • Diabetic retinopathy

  • Type 2 diabetes mellitus

  • Renal disease

  • Diabetes

Biomarkers

  • Nucleoside diphosphate kinase A

  • Hemoglobin A1c

  • High sensitivity C-reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final